Older Publications

All publications in peer-reviewed journals.  

Publications at Colorado State University:

181. “Antidiabetic, chemical and physical properties of organic vanadates as presumed transition state inhibitors for phosphatases” Debbie C. Crans. J. Org. Chem. 2015, 80 (24), pp 11899-11915. http://dx.doi.org/10.1021/acs.joc.5b02229. This article was featured on the cover.

180. “MenI, a novel menaquinone reductase in Mycobacterium tuberculosis is required for survival in macrophages,” Ashutosh Upadhyay, Fabio Fontes, Mercedes Gonzalez-Juarrero, Michael R. McNeil, Debbie C. Crans, Mary Jackson, and Dean C. Crick. ACS Central Science, 2015, 1, pp 292-302.

179. “Vanadium-protein complexes: Phosphatase inhibitors favor the trigonal bipyramidal transition state geometries,” Craig C. McLauchlan, Benjamin J. Peters, Gail R. Willsky, and Debbie C. Crans. Coord. Chem. Rev., 2015, 301-302, pp 163-199. The article is featured on the Cover.

178. “High-frequency and -field electron paramagnetic resonance of vanadium(IV, III, and II) complexes,” Jurek Krzystek, Andrew Ozarowski, Joshua Telser, and Debbie C. Crans. Coord. Chem. Rev., 2015, 301-302, pp 123-133.

177. “Evaluating transition state structures of vanadium-phosphatase protein complexes using shape analysis,” Irma Sanchez-Lombardo, Santiago Alvarez, Craig C. McLauchlan, and Debbie C. Crans. J. Inorg. Biochem. 2015, 147, pp 153-164.

176. “NMR crystallography for structural characterization of oxovanadium(V) complexes: Deriving coordination geometry and detecting weakly coordinated ligands at atomic resolution in the solid state,” Mingyue Li, Jenna Yehl, Guangjin Hou, Pabitra B. Chatterjee, Amir Goldbourt, Debbie C. Crans, and Tatyana Polenova. Inorg. Chem., 2015, 54, pp 1363-1374.

175. “Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis,” Wei Li, Ashutosh Upadhyay, Fabio L. Fontes, E. Jeffrey North, Yuehong Wang, Debbie C. Crans, Anna E. Grzegorzewicz, Victoria Jones, Scott G. Franzblau, Richard E. Lee, Dean C. Crick, and Mary Jackson, Antimicrob. Agents Chemotheraphy. 2014, 58 (11), pp 6413-6423.

174. “Electron transfer rate enhancements in nanosized waterpools,” Bret B. Lorenz, Debbie C. Crans, and Michael D. Johnson. Eur. J. Inorg. Chem., 2014, 27, pp 4537-4540.

173. “Trigonal bipyramidal or square pyramidal coordination geometry? Phosphatase inhibiting vanadium compounds,” Debbie C. Crans, Craig C. McLauchlan, and Michael L. Tarlton. Eur. J. Inorg. Chem., 2014, 27, pp 4450-4468.

172. “Spectroscopic characterization of L-ascorbic acid-induced reduction of vanadium(V) dipicolinates: Forming V(III) and V(IV) complexes from V(V) dipicolinate derivatives,” Dorothy C. Horton, Don VanDerveer, J. Krzystek, Joshua Telser, Thomas Pittman, Debbie C. Crans, and Alvin A. Holder. Inorg. Chem. Acta., 2014, 420, pp 112-119.

171. “Guanylurea metformium double salt of decavanadate, (HGU+)4(HMet+)2(V10O286-)·2H2O,” Aungkana Chatkon, Alexa Barres, Nuttaporn Samart, Sarah Boyle, Kenneth J. Haller, and Debbie C. Crans. Inorg. Chem. Acta., 2014, 420, pp 85-91.

170. “Interaction of a biguanide compound with membrane model interface systems; Probing properties of antimalaria and antidiabetic compounds” Nuttaporn Samart, Cheryle N. Beuning, Kenneth Haller, Christopher D. Rithner, and Debbie C. Crans. Langmuir, 2014, 30, pp 8697-8706.

169. “Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats,” Mingxia Xie, Deliang Chen, Fang Zhang, Gail R. Willsky, Debbie C. Crans, and Wenjun Ding. J. Inorg. Biochem., 2014, 136, pp 47–56.

168. “Correlation of insulin enhancing properties of vanadium dipicolinate complexes in model membrane systems: Phospholipid langmuir monolayers and AOT reverse micelles,” Audra G. Sostarecz, Ernestas Gaidamauskas, Steve Distin, Sandra J. Bonetti, Nancy E. Levinger, and Debbie C. Crans. Chem. Eur. J., 2014, 20, pp 5149-5159.

167. “Interaction of decavanadate with interfaces and biological model membrane systems: Characterization of soft oxometalate systems,” Nuttaporn Samart, Jessica Saeger, Kenneth J. Haller, Manuel Aureliano, and Debbie C. Crans. J. Mol. Eng. Mat., 2014, 2, pp 1-21.

166. “The active form of anti-diabetic vanadium compounds in the organism,” Yutaka Yoshikawa, Hiromu Sakurai, Debbie C. Crans, Giovanni Micera, and Eugenio Garribba. Dalton Transactions, 2014, 43, pp 6965-6972.

165. “Effect of ancillary ligand on electronic structure as probed by 51V solid-state NMR spectroscopy for vanadium-o-dioxolene complexes,” Olga Goncharov-Zapata, Pabitra B. Chatterjee, Guangjin Hou, Laurence L. Quinn, Mingyue Li, Jenna Yehl, Debbie C. Crans, and Tatyana Polenova. CrystEngComm, 2013, 15, pp 8776-8783.

164. “Metal speciation in health and medicine represented by iron and vanadium,” Debbie C. Crans, Kellie A. Woll, Kestutis Prusinskas, Michael D. Johnson, and Eugenijjus Norkus. Inorg. Chem., 2013, 52, pp 12264-12275. (IC Forum dx.doi.org/10.1021/ic4007873)

163. “Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients,” Gail R. Willsky, Katherine Halvorson, Michael E. Godzala III, Lai-Har Chi, Mathew Most, Peter Kaszynski, Debbie C. Crans, Allison B. Goldfine and Paul J. Kostnyniak. Metallomics, 2013, 5 (11), pp 1491-1502.

162. “Cation exchange, solvent free synthesis and packing patterns of quinolinium nickel(II) dipicolinates,” Babulal Das, Debbie C. Crans and Jubaraj B. Baruah. Inorg. Chim. Acta., 2013, 408, pp 204-208.

161. “Using real time RT-PCR analysis to determine gene expression patterns in RBL-2H3 cells in response to insulin, glucose and the anti-diabetic bis(maltolato)oxovanadium(IV),” Abeer Al-Qatati, Amber L. Wolf-Ringwall, Gerrit J. Bouma, Debbie C. Crans, B. George Barisas and Deborah A. Roess. J. Al Azhar University-Gaza (Natural Sciences), 2013, 15, pp 129-152.

160. “Raft localization of Type1 Fcε receptor and degranulation of RBL-2H3 cells exposed to decavanadate, a structural model for V2O5,” Abeer Al-Qatati, Fabio L. Fontes, B. George Barisas, Dongmei Zhang, Deborah A. Roess and Debbie C. Crans. Dalton Transactions, 2013, 2 (33), pp 11912 – 11920.

159. “Counterion affects interaction with interfaces: The antidiabetic drugs metformin and decavanadate,” Aungkana Chatkon, Pabitra B. Chatterjee, Myles A Sedgwick, Kenneth J. Haller and Debbie C. Crans. Eur. J. Inorg. Chem., 2013, 10-11, pp 1859-1868.

158. “Stabilization of a vanadium(V)-catechol complex by compartmentalization and reduced solvation inside reverse micelles,” Brant G. Lemons, David Richens, Michael D. Johnson, Ashley Anderson, Myles A Sedgwick, and Debbie C. Crans. New J. Chem., 2013, 37, pp 75-81. (Hot topic issue. Cover Manuscript.)

157. “Correlating Proton Transfer Dynamics to Probe Location in Confined Environments,” Myles Sedgwick, Richard L. Cole, Christopher D. Rithner, Debbie C. Crans and Nancy E. Levinger. J. Amer. Chem. Soc., 2012, 134, pp 11904-11907.

156. “Solid-to-solid oxidation of a vanadium(IV) to be a vanadium(V) compound: Chemistry of a sulfur containing siderophore,” Pabitra B. Chatterjee and Debbie C. Crans, Inorg. Chem., 2012, 51, pp 9144-9146.

155. “Redox activity in a vanadium(V) o-dioxolene complex is modulated by protonation state as indicated by 51V solid-state NMR and density functional theory calculations,” Pabitra B. Chatterjee, Olga Goncharov-Zapata, Guangjin Hou, Tatyana Polenova and Debbie C. Crans. Eur. J. Inorg. Chem., 2012, pp 4644-4651.

154. “The conundrum of pH in water nanodroplets: Sensing pH in reverse micelle water pools,” Debbie C. Crans and Nancy E. Levinger. Acc. Chem. Res., 2012, 45, pp 1637-1645.

153. “Insulin and bis(maltolato)oxovanadium(IV) (BMOV) reduce insulin receptor lateral diffusion and increase receptor confinement in membrane microdomains,” Peter W. Winter, Abeer Al-Qatati, Amber Wolf-Ringwall, Samantha Schoeberl, Alan K. Van Orden, B. George Barisas, Deborah A. Roess and Debbie C. Crans. Dalton Transactions, 2012, 41 (21), pp 6419-6430.

152. “Insulin receptors and downstream substrates associate with membrane microdomains after treatment with insulin or chromium(III) picolinate,” Abeer Al-Qatati, Peter W. Winter, Amber L. Wolf-Ringwall, Pabitra B. Chatterjee, Alan K. van Orden, Debbie C. Crans, Deborah A. Roess and B. George Barisas. Cell Biochem. Biophys., 2012, 62 (3), pp 441-450.

151. “Switching off electron transfer reactions in confined media: Reduction of [Co(dipic)2]- and [Co(edta)]- by hexacyanoferrate(II),” Michael D. Johnson, Bret B. Lorenz, Patricia C. Wilkins, Brant G. Lemons, Bharat Baruah, Nathan Lamborn, Michelle Stahla, Pabitra B. Chatterjee, David T. Richens and Debbie C. Crans. Inorg. Chem., 2012, 51 (20), pp 2757-2765.

150. “Quantification of foscarnet with chromogenic and fluorogenic chemosensors: Indicator displacement assays based on metal ion coordination with catechol ligand moiety,” Ernestas Gaidamauskas, Debbie C. Crans, Helen Parker, Kanokkarn Saejueng, Boris A. Kashemirov and Charles E. McKenna. New J. Chem., 2011, 35 (12), pp 2877-2883.

149. “Antidiabetic vanadium compound and membrane interfaces: Interface facilitated metal complex hydrolysis” Debbie C. Crans, Samantha Schoeberl, Ernestas Gaidamauskas, Bharat Baruah and Deborah A. Roess. J. Biol. Inorg. Chem., 2011, 16, pp 961-972.

148. “An AOT-lecithin based gel formulation for intracavitary administration of breast cancer drugs” Kellie A. Woll, Elie J. Schuchardt, Claire R. Willis, Christopher D. Ortengren, Noah Hendricks, Mitch Johnson, Ernestas Gaidamauskas, Bharat Baruah, Audra G. Sostarecz, Deanna R. Worley, David W. Osborne and Debbie C. Crans. Chemistry & Biodiversity, 2011, 8 (12), pp 2195-2210.

147. “Electronic properties of non-innocent compounds probed by solid–state 51V NMR spectroscopy: o-dioxolene vanadium complexes,” Pabitra B. Chatterjee, Olga Goncharov-Zapata, Laurence L. Quinn, Guangjin Hou, Hiyam Hamaed, Robert W. Schurko, Tatyana Polenova, and Debbie C. Crans. Inorg. Chem., 2011, 50, pp 9794-9803. (Contribution invited to the Inorganic Chemistry Forum on Redox Active Ligands)

146. “Layered structure of room temperature ionic liquids in microemulsions by multinuclear NMR spectroscopic studies,” R. Dario Falcone, Bharat Baruah, Ernestas Gaidamauskas, Christopher D. Rithner, N. Mariano Correa, Juana J. Silber, Debbie C. Crans and Nancy E. Levinger, Chem. Eur. J., 2011, 17, pp 6837-6846.

145. “Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with Streptozotocin induced diabetes,” Gail Ruth Willsky, Lai-Har Chi, Michael E Godzalla, III, Paul J Kostyniak, Jason J Smee, Alejandro M Trujillo, Josephine A Alfano, Wenjin Ding, Zihua Hu and Debbie C. Crans, Coor. Chem. Rev., 2011, 19-20, pp 2258-2269.

144. “How environment affects drug activity: Localization, compartmentalization and reactions of a vanadium insulin-enhancing compound, dipicolinatooxovanadium(V),” Debbie C. Crans, Alejandro M. Trujillo, Philip S. Pharazyn and Mitchell D. Cohen, Coor. Chem. Rev., 2011, 19-20, pp 2178-2192.

143. “Reduced molybenum-oxide-based core–shell hybrids: “Blue” electrons are delocalized on the shell,” Ana Maria Todea, Julia Szakacs, Sanjit Konar, Hartmut Bçgge, Debbie C. Crans, Thorsten Glaser, Helene Rousseliere, Rene Thouvenot, Pierre Gouzerh and Achim Muller, Chem. Eur. J., 2011, 17, pp 6635-6642.

142. “Acidification of reverse micellar nanodroplets by CO2,” Nancy E. Levinger, Lauren C. Rubenstrunk, Bharat Baruah and Debbie C. Crans, J. Am. Chem. Soc., 2011, 133, pp 7205-7213. (Highlighted in Science, 332, (6031), 13 May 2011.)

141. “Coexisting aggregates in mixed Aerosol OT and cholesterol microemulsions,” Myles A. Sedgwick, Alejandro M. Trujillo, Noah Hendricks, Nancy E. Levinger and Debbie C. Crans, Langmuir, 2011, 27 (3), pp 948-954.

140. “Effect of micellar and reverse micellar interface on solute location: 2,6-pyridinedicarboxylate in CTAB micelles and CTAB and AOT reverse micelles,” Ernestas Gaidamauskas, David P. Cleaver, Pabitra B. Chatterjee and Debbie C. Crans, Langmuir, 2010, 26, pp 13153-13161.

139. “Is vanadate reduced by thiols under biological conditions?: Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution” Debbie C. Crans, Boyan Zhang, Ernestas Gaidamauskas, Anastasios D. Keramidas, Gail R. Willsky and Chris R. Roberts, Inorg. Chem., 2010, 49, pp 4245-4256.

138. “Effects of metal compounds with distinct physicochemical properties on iron homeostasis and anti-bacterial activity in the lungs: Cr and V,” Mitchell D. Cohen, Maureen Sisco, Kotaro Yoshida, Lung-chi Chen, Judith T. Zelikoff, Jason Smee, Alvin A. Holder, Jacqueline Stonehuerner, Debbie C. Crans and Andrew J. Ghio, Inhalation Toxicology, 2010, 22 (2), pp 169-178.

137. “Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes” Maria Joao Pereira, Eugenia Carvalho, Jan W. Eriksson, Debbie C. Crans and Manuel Aureliano, J. Inorg. Biochem., 2009, 103, 1687-1692.

136. “Complexation of bisphosphonates with Ytterbium(III): Application of phosphate and ATP detection assay based on Yb3+-pyrocatechol violet,” Ernestas Gaidamauskas, Helen Parker, Boris A. Kashemirov, Alvin A. Holder, Kanokkarn Saejueng, Charles E. McKenna and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 1652-1657 (DOI:10.1016/j.jinorgbio.2009.09.006).

135. “51V solid-state NMR and density functional theory studies of eight-coordinate non-oxo vanadium complexes: Oxidized amavadin,” Kristopher J. Ooms, Stephanie E. Bolte, Bharat Baruah, M. A. Choudhary, Debbie C. Crans and Tatyana Polenova, Dalton Trans., 2009, 3262-3269 (DOI: 10.1039/b820383k).

134. “What’s inside a nonionic reverse micelle? Probing the interior of Igepal reverse micelles using decavanadate,” Myles A. Sedgwick, Debbie C. Crans and Nancy E. Levinger, Langmuir, 2009, 25, 5496-5503.

133. “Impact of confinement and interfaces on coordination chemistry: Probing oxovanadate reactions including proton transfer reactions in reverse micelles,” Debbie C. Crans, Bharat Baruah, Allison Ross and Nancy E. Levinger, Coord. Chem. Rev., 2009, 253, 2178-2185.

132. “Electron transfer in non-Oxo vanadium(IV) and (V) complexes: Kinetic studies of an amavadin model” Jeremy M. Lenhardt, Bharat Baruah, Debbie C. Crans and Michael D. Johnson, Pure Appl. Chem., 2009, 81, 1241-1249.

131. “Anti-diabetic effects of vanadium (III, IV, V) – chlorodipicolinate complexes in streptozotocin-induced diabetic rats,” Ming Li, Wenjun Ding, Jason J. Smee, Bharat Baruah, Gail R. Willsky and Debbie C. Crans, BioMetals, 2009, 103, 585-905.

130. “Chloro-substituted dipicolinate vanadium complexes: Synthesis, solution, solid-state and insulin enhancing properties,” Jason J. Smee, Jason A. Epps, Kristopher Ooms, Stephanie Bolte, Tatyana Polenova, Bharat Baruah, Luqin Yang, Wenjun Ding, Ming Li, Gail R. Willsky, Agnete la Cour, Oren P. Anderson and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 575-584.

129. “Decavanadate (V10O286-) and oxovanadates: Oxometalates with many biological activities” Manuel Aureliano and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 536-546.

128. “Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats,” Ming Li, Jason J. Smee, Wenjun Ding and Debbie C. Crans, J. Inorg. Biochem., 2009, 103, 585-589.

127. “Deprotonation of β-cyclodextrin in alkaline solutions,” Ernestas Gaidamauskas, Eugenijus Norkus, Eugenijus Butkus, Debbie C. Crans and Giedre Grinciene, Carbohydrate Res., 2009344, 250-254.

126. “Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV),” M. Li, W. Ding, B. Baruah, Debbie C Crans and R. Wang, J. Inorg. Biochem., 2008, 102, 1846-1853. (This paper was highlighted by F1000)

125. “Penetration of negatively charged lipid interfaces by the doubly deprotonated dipicolinate,” Debbie C. Crans, Alejandro M. Trujillo, Sandra Bonetti, Christopher D. Rithner, Bharat Baruah and Nancy E. Levinger, J. Org. Chem., 2008, 73, 9633-9640.

124. “Metal complexation chemistry used for phosphate and nucleotide determination: An investigation of the Yb3+-pyrocatechol violet sensor,” Ernestas Gaidamauskas, Kanokkarn Saejueng, Alvin A. Holder, Subalita Baruah, Boris A. Kashemirov, Debbie C. Crans and Charles E. McKenna, J. Biol. Inorg. Chem, 2008, 13, 1291-1299.

123. “51V NMR and density functional theory studies of vanadium environments in V(V)O2 dipicolinic acid complexes,” Stephanie E. Bolte, Kristopher J. Ooms, Tatyana Polenova, Bharat Baruah, Debbie C. Crans and Jason J. Smee, J. Chem. Phys., 2008, 128, 052317/1-052317/11.

122. “Do probe molecules influence water in confinement?,” Bharat Baruah, Laura A. Swafford, Debbie C. Crans and Nancy E. Levinger, J. Phys. Chem. B, 2008, 112, 10158-10164.

121. “1H NMR studies of aerosol-OT reverse micelles with alkali and magnesium counterions: preparation and analysis of MAOTs,” Michelle L. Stahla, Bharat Baruah, Dustin M. James, Michael D. Johnson, Nancy E. Levinger and Debbie C. Crans, Langmuir, 2008, 24, 6027-6035.

120. “Effects of vanadium-containing compounds on membrane lipids and on microdomains used in receptor-mediated signaling,” Deborah A. Roess, Steven M. L. Smith, Peter Winter, Jun Zhou, Ping Dou, Bharat Baruah, Alejandro M. Trujillo, Nancy E. Levinger, Xioda Yang, B. George Barisas and Debbie C. Crans, Chemistry & Diversity, 2008, 5, 1558-1570.

119. “Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds,” Manuel Aureliano, v Rui O. Duarte, J.J.G. Moura and Debbie C. Crans, Inorg. Chem., 2008, 47, 5677-5684.

118. “Impairment of ascorbates’ anti-oxidant properties in confined media: Inter and intramolecular reactions with air and with vanadate at acidic pH,” Debbie C. Crans, Bharat Baruah, Ernestas Gaidamauskas, Brant G. Lemons and Michael D. Johnson, J. Inorg. Biochem, 2008, 102, 1334-1347.

117. “Anti-diabetic effects of cesium aqua (N,N’ethylene(salicylideneimiato)-5-sulfonato) oxovanadium(IV) dihydrate in streptozotocin – induced diabetic rats,” Ming Li, D. Wei, Weijin Ding, Bhatat Baruah and Debbie C. Crans, Biol. Trace Element Res., 2008, 121, 226-232.

116. “4-amino and 4-nitrodipicolinatovanadium(V) complexes and their hydroxylamido derivatives: Synthesis, aqueous and solid state properties,” Jason J. Smee, Jason A. Epps, Guillaume Teissedre, Mandy Maes, Nichola Harding, Luqin Yang, Bharat Baruah, Susie M. Miller, Oren P. Anderson, Gail R. Willsky and Debbie C. Crans, Inorg. Chem., 2007 46, 9827-9840.

115. “Investigating the vanadium environments in hydroxylamido V(V) dipicolinate complexes using 51V NMR spectroscopy and density functional theory,” Kristopher J. Ooms, Stephanie E. Bolte, Jason Smee, Bharat Baruah, Debbie C. Crans and Tatyana Polenova, Inorg. Chem., 2007, 46, 9285-9293.

114. “Chelation of vanadium(V) by difluoromethylene bisphosphonate, a structural analog of pyrophosphate,” Debbie C. Crans, Alvin A. Holder, Tapan Kumar Saha, G. K. Surya Prakash, Muhammed Yousufuddin, Roman Kultyshev, Rehana Ismail, Myron F. Goodman, James Borden and Jan Florian, Inorg. Chem., 2007, 46, 6723-6732.

113. “Comparing administration route in rats with streptozocin-induced diabetes and inhibition of myoblast growth of vanadium [V(III), V(IV) and V(V)] dipicolinic acid complexes,” Gail R. Willsky, Michael E. Godzalla III, Paul J. Kostyniak, Lai-Har Chi, Rohit Gupta, Violet G. Yuen, John H. McNeill, Mohammad Mahroof-Tahir, Jason J. Smee, Luqin Yang, Aaron Kobernick, Shari Watson, and Debbie C. Crans, ACS Symposium Series, 2007, 974, 93-109.

112. “Do vanadium compounds drive reorganization of the plasma membrane and activation of insulin receptors with lipid rafts,” Deborah A. Roess, Steven M. L. Smith, Alvin A. Holder, Bharat Baruah, Alejandro M. Trujillo, Daniel Gilsdorf, Michelle L. Stahla, and Debbie C. Crans, ACS Symposium Series, 2007, 974, 121-134.

111. “Electron spin lattice relaxation of V(IV) complexes in glassy solutions between 15 and 70 K,” Alistair J. Fielding, Dong Bin Back, Michael Engler, Bharat Baruah, Debbie C. Crans, Gareth R. Eaton and Sandra S. Eaton, ACS Symposium Series, 2007, 974, 364-375.

110. “Simple oxovanadates as multiparameter probes of reverse micelles,” Bharat Baruah, Debbie C. Crans and Nancy E. Levinger, Langmuir, 2007, 23, 6510-6518.

109. “Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Vanadium agents,” M.D. Cohen, C. Prophete, M. Sisco, L. Chen, J.T. Zelikoff, J.J. Smee, A.A. Holder, A.J. Ghio, J.D. Stonehuerner and Debbie C. Crans, J. Immunotox. 2007, 4(1), 49-60.

108. “Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate,” GR Willsky, LH Chi, Y Liang, DP Gaile, Z Hu, Debbie C. Crans, Physiological Genomics, 2006, 26(3), 192-201.

107. “Oxovanadates: A novel probe for studying lipid-water interfaces,” Debbie C Crans, Bharat Baruah and Nancy E Levinger, Biomedicine & Pharmacotherapy, 2006, 60(4), 174-181.

106. “The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes,” Y. Zhang, X.D. Yang, K. Wang and Debbie C. Crans, J. Inorg. Biochem., 100 (1), 2006, 80-87.

105. “When water is not water? Exploring water confined in large reverse micelles using a highly charged inorganic molecular probe,” Bharat Baruah, Jennifer M. Roden, Myles Sedgwick, N. Mariano Correa, Debbie C. Crans and Nancy E. Levinger, J. Am. Chem. Soc., 2006, 128, 12758-12765.

104. “Self-exchange electron transfer in high oxidation state non-oxo metal complexes: Amavadin,” Jeremy Lenhardt, Bharat Baruah, Debbie C. Crans and Michael D. Johnson, Chem. Comm., 2006, 4641-4643.

103. “Spectrometric and electrochemical investigations of vanadium(V) and vanadium(IV) tartrate complexes in solution,” Ahmad R. Khan, Debbie C. Crans, Rasa Pauliukate and Eugene Norkus, J. Brazil. Chem. Soc., 2006, 17, 895-904.

102. “Molecule probe location in reverse micelles determined by NMR dipolar interactions,” Debbie C. Crans, Christopher D. Rithner, Bharat Baruah, Bridget L. Gourley and Nancy E. Levinger, J. Am. Chem. Soc., 2006, 128, 4437-4445.

101. “Transition state analogues for nucleotidyl transfer reactions: Structure and stability of pentavalent vanadate and phosphate ester dianions,” James Borden, Debbie C. Crans and Jan Florian, J. Phys. Chem. B, 2006, 110, 14988-14999.

100. “Reduction of vanadium(V) by L-ascorbic acid at low and neutral pH: Kinetic, mechanistic and spectroscopic characterization,” Patricia C. Wilkins, Michael D. Johnson, Alvin A. Holder and Debbie C. Crans, Inorg. Chem., 2006, 45, 1471-1479.

99. “Pulmonary immunotoxic potentials of metals are governed by select physicochemical properties: Chromium agents,” M.D. Cohen, M. Sisco, C. Prophete, L. Chen, J.T. Zelikoff, J.J. Smee, A.A. Holder and Debbie C. Crans, J. of Immunotox., 2006, 3, 69-81.

98. “Fifteen year of dancing with Vanadium,” Debbie C. Crans, Pure Appl. Chem., 2005, 77, 9, 1497-1527.

97. “Aqueous chemistry of the vanadiumIII and the VIII-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats,” Péter Buglyó, Debbie C. Crans, Eszter M. Nagy, Ruby Lisa Lindo, Luqin Yang, Jason J. Smee, Lai-Har Chi, Michael E. Godzala III and Gail R. Willsky, Inorg. Chem., 2005, 44, 5416-5427.

96. “Evidence of two-step deprotonation of mannitol in aqueous solution,” Ernestas Gaidamauskas, Eugenijus Norkus, Jurate Vaiciuniene, Debbie C. Crans, Tapani Vuorinen, Jane Jaciauskiene and Gintaras Baltrunas, Carbohydrate Res., 2005, 340, 1553-1556.

95. “Interaction of dipicolinatodioxovanadium(V) with polyatomic cations and surfaces in reverse micelles,” Jessica Stover, Christopher D. Rithner, Rae Ann Inafuku, Debbie C. Crans and Nancy E. Levinger, Langmuir, 2005, 21, 6250-6258.

94. “Interaction of pyridine-2,5-dicarboxylic acid with heavy metal ions in aqueous solutions,” Eugenijus Norkus, Ernestas Gaidamauskas, Irena Stalnioniene and Debbie C. Crans, Heteroatom Chem., 2005, 16(4), 285-291.

93. “Inhibition of yeast growth by molybdenum-hydroxylamido complexes correlates with their presence in media at differing pH values”, Debbie C. Crans, Jason J. Smee, Edita G. Gaidamauskiene, Oren P. Anderson, Susie M. Miller, Wenzheng Jin, Ernestas Gaidamauskas, Etienne Crubellier, Rose Grainda, Lar-Har Chi and Gail R. Willsky, J. Inorg. Biochem., 2004, 98, 1837-1850.

92. “The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds,” Debbie C. Crans, Jason J. Smee, Ernestas Gaidamauskas and Luqin Yang, Chem. Rev., 2004, 104(2), 849-902.

91. “The permeability and cytotoxicity of insulin-mimetic vanadium compounds,” Xiao-Gai Yang, Xiao-Da Yang, Lan Yuan, Kui Wang and Debbie C. Crans, Pharmaceutical Research, 2004, 21(6), 1026-1033.

90. “Vanadium(IV) and vanadium(V) complexes of dipicolinic acid and derivatives: Synthesis, X-ray structure, solution state properties and effects in rats with STZ-induced diabetes,” Debbie C. Crans, Mohammad Mahroof-Tahir, Michael D. Johnson, Patricia C. Wilkins, Luqin Yang, Karen Robbins, Alison Johnson, Josephine A. Alfano, Michael E. Godzala, III, La Tanya Austin and Gail R. Willsky, Inorg. Chem. Acta., 2003, 356C, 365-378.

89. “Vanadium(IV/V) speciation of pyridine-2,6-dicarboxylic acid and 4-hydroxy-pyridine-2,6-dicarboxylic acid complexes: Potentiometry, EPR spectroscopy and comparison across oxidation states,” Tamas Jakusch, Wenzheng Jin, Luqin Yang, Tamas Kiss, Debbie C. Crans, J. Inorg. Biochem., 2003, 95(1), 1-13.

88. “Applications of paramagnetic NMR spectroscopy for monitoring transition metal complex stoichiometry and speciation,” Debbie C. Crans, Luqin Yang, Ernestas Gaidamauskas, A. Raza Khan, Wenzheng Jin and Ursula Simonis, ACS Symposium Series, 2003, 858, 304-332.

87. “The membrane transport of vanadium compounds and the interaction with the erythrocyte membrane,” Xiaogai Yang, Kui Wang, Jingfen Lu and Debbie C. Crans, Coord. Chem. Rev., 2003, 237(1-2), 103-111.

86. “Interaction of pyridine- and 4-hydroxypyridine-2,6-dicarboxylic acids with heavy metal ions in aqueous solutions,” Eugenijus Norkus, Irena Stalnioniene and Debbie C. Crans, Heteroatom Chemistry, 2003, 14(7), 625-632.

85. “(4-hydroxypyridine-2,6-dicarboxylate) oxovanadate(V) – a new insulin-like compound: chemistry, effects on myoblast and yeast cell growth and effects on hyperglycemia in rats with STZ-induced diabetes,” Debbie C. Crans, Luqin Yang, Josephine A. Alfano, Lai-Har Chi, Wenzheng Jin, Mohammad Mahroof-Tahir, Karen Robbins, Masoud M. Toloue, Leong K. Chan, Andrew J. Plante, Rebecca Z. Grayson and Gail R. Willsky, Coord. Chem. Rev., 2003, 237, 13-22.

84. “Cu(II), Pb(II) and Cd(II) complex formation with pyridine-2,6-dicarboxylate and 4-hydroxypyridine-2,6-dicarboxylate in aqueous solutions,” E. Norkus, I. Stalnioniene and Debbie C. Crans, Chemija (Vilnius), 2002, 13, N 4, 194-202.

83. “Transition and heavy metal ions complex formation with 2,5-pyridinedicarboxylic acid,” E. Norkus, I. Stalnioniene and Debbie C. Crans, Chemine technologija (Kaunas), 2002, N 4(25), 9-12.

82. “Speciation of transition metal ion complexes in alkaline solutions of alditols. 2. Cu(II) complex formation with D-sorbitol,” E. Norkus, J. Vaiciuniene, J. Reklaitis and Debbie C. Crans, Chemija (Vilnius), 2002, 13, N 3, 129-137.

81. “Speciation of transition metal ion complexes in alkaline solutions of alditols. 1. Cu(II) complex formation with D-mannitol,” E. Norkus, J. Vaiciuniene, J. Reklaitis, E. Gaidamauskas and Debbie C. Crans, Chemija (Vilnius), 2002, 13, N 3, 119-128.

80. “Inelastic neutron scattering on three mixed-valence dodecanuclear polyoxovanadate clusters,” Reto Basler, Gregory Chaboussant, Andreas Sieber, Hansperter Andres, Mark Murie, Paul Kögerler, Hartmut Bögge, Debbie C. Crans, Erich Krickemeyer, Stefan Janssen, Hannu Mutka, Achim Müller and Hans-Ulrich Güdel, Inorg. Chem., 2002, 41, 5675-5685.

79. “4-hydroxypyridine-2,6-dicarboxylatooxovanadium(V) complexes: Solid state and aqueous chemistry,” Luqin Yang, Agnete la Cour, Oren P. Anderson and Debbie C. Crans, Inorg. Chem., 2002, 41, 6322-6331.

78. “Rational synthesis and X-ray structures of [MnII4(H2O)2(AsVW9O34)2]10- from [AsIII4W40O140]28-, MnO4- and Mn++,” Cristina Rosu, Debbie C. Crans and Timothy J. R. Weakley, Polyhedron, 2002, 21, 259-262.

77. “Cobalt(II) and cobalt(III) dipicolinate complexes: Solid state, solution and in vivo insulin-like properties,” Luqin Yang, Debbie C. Crans, Susie M. Miller, Agnete la Cour, Oren P. Anderson, Peter M. Kaszynski, Michael E. Godzala, III, LaTanya D. Austin and Gail R. Willsky, Inorg. Chem., 2002, 41, 4859-4871.

76. “Bis(acetylamido)oxovanadium(IV) complexes: Solid state and solution studies,” Debbie C. Crans, A. Raza Khan, Mohammad Mahroof-Tahir, Sujit Mondal, Susie M. Miller, Agnete la Cour, Oren P. Anderson, Tamas Jakusch and Tamas Kiss, Dalton Transactions, 2001, 3337-3345.

75. “Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV),” G. R. Willsky, A. B. Goldfine, P. J. Kostyniak, J. H. McNeill, L. Yang, A. R. Khan and Debbie. C. Crans, J. Inorg. Biochem., 2001, 85, 33-42.

74. “Methylation of neutral pseudotetrahedral zinc thiolate complexes: Model reactions for alkyl group transfer to sulfur by Zn-containing enzymes,” Chris R. Warthen, Brain S. Hammes, Carl J. Carrano and Debbie C. Crans, J. Biol. Inorg. Chem., 2001, 6, 82-90.

73. “Aqueous chemistry of ammonium dipicolinatooxovanadium(V): The first organic vanadium(V) insulin-mimetic compound,” Debbie C. Crans, Luqin Yang, Tamas Jakusch and Tamas Kiss, Inorg. Chem., 2000, 39, 4409-4416.

72. “Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds,” Debbie C. Crans, J. Inorg. Biochem., 2000, 80, 123-131.

71. “Chemistry and insulin mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives,” Sean S. Amin, Kirk Cryer, Boyan Zhang, Sandra S. Eaton, Oren P. Anderson, Susie M. Miller, Benedicte A. Reul, Sonia M. Brichard and Debbie C. Crans, Inorg. Chem., 2000, 39, 406-416.

70. “Solution characterization of vanadium(V) and (IV) N-(phosphonomethyl)iminodiacetate complexes: Direct observation of one enantiomer converting to the other in an equilibrium mixture,” Debbie C. Crans, Feilong Jiang, Iman Boukhobza, Istvan Bodi and Tamas Kiss, Inorg. Chem., 1999, 38, 3275-3282.

69. “Effects of vanadium complexes with organic ligands on glucose metabolism: A comparison study in diabetic rats,” B. A. Reul, S. S. Amin, J. P. Buchet, L. N. Ongemba, Debbie. C. Crans and S. M. Brichard, British J. Pharm., 1999, 126, 467-477.

68. “Dinuclear oxovanadium(IV) (phosphonomethyl)lminodiacetate complexes: Na4[V2O2{(O)2P(O)-CH2N(CH2COO)2}2]10H2O and Na8[V2O2{(O)2P(O)Ch2N(CH2COO)2}2]216H2O,” Debbie C. Crans, Feilong Jiang, Oren P. Anderson and Susie M. Miller, Inorg. Chem., 1998, 37, 6645-6655.

67. “Speciation in vanadium bioinorganic systems. 5. Interactions between vanadate, uridine and imidazole – an aqueous potentiometric, 51V and 17O NMR Study,” Katarine Elvingston, Anastasios D. Keramidas, Debbie C. Crans, and Lage Pettersson, Inorg. Chem., 1998, 37, 6163-6160.

66. “Stepwise cluster assembly using VO2(acac) as a precursor: cis-[VO(OCH(CH3)2)(acac)2], [V2O2(-OCH3)2(acac)2(OCH3)2], [V3O3{,-(OCH2)3CCH3}2(acac)2(OC2H5)], [V4O4(-O)2(-OCH3)2(3-OCH3)2(acac)2(OCH3)2]•2CH3CN,” Feilong Jiang, Oren P. Anderson, Susie M. Miller, John Chen, Mohammad Mahroof-Tahir and Debbie C. Crans, Inorg. Chem., 1998, 37, 5439-5451.

65. “Vanadium(V) complexes of polydentate Aminoalcohols: Fine-tuning complex properties,” Debbie C. Crans and Iman Boukhobza, J. Am. Chem. Soc., 1998, 120, 8069-8078.

64. “Insulin-like effects of vanadium; Reviewing in vivo and in vitro studies and mechanisms of action,” Yoram Shechter, Gerard Elberg, Assia Shisheva, Dov Gefel, Natesampillai Sekar, Sun Qian, Rafi Bruck, Eythan Gershonov, Debbie C. Crans, Y. Toldwasser, Mati Fridkin and Jinping Li, In ACS Symposium Series, Debbie. C. Crans and A. S. Tracey, Eds.; (from the 1997 Fifth Chemical Congress of North America Conference Proceedings, Cancun, Mexico); ACS Symposium Ser., 1998, 711, 308-315.

63. “Peroxo-, hydroxylamido- and acac-derived vanadium complexes,” Debbie C. Crans, Alan S. Tracey, In ACS Symposium Series, D. Crans and A. S. Tracey, Eds.; (from the 1997 Fifth Chemical Congress of North America Conference Proceedings Cancun, Mexico); ACS Symposium Ser., 1998, 711, 82-103.

62. “The chemistry of vanadium in aqueous and nonaqueous solution chemistry,” Debbie C. Crans, Alan S. Tracey (Eds.), In ACS Symposium Series, Debbie Crans and A. S. Tracey, Eds.; (from the 1997 Fifth Chemical Congress of North America Conference Proceedings Cancun, Mexico); ACS Symposium Ser., 1998. 711, 2-29.

61. “Metal-carbohydrate complexes in solution,” Jean-Franqois Verchere, Stella Chapelle, Feibo Xin and Debbie C. Crans, Prog. Inorg. Chem., 1998, 47, 837-945.

60. “Chemistry of relevance to vanadium in the environment,” Debbie C. Crans, Shahid Amin and Anastasios D. Keramidas, Vanadium in the Environment, Part I, J. Nriagu, Ed.; John Wiley & Sons, Inc.: New York, 1998, 30, 73-96.

59. “Vanadium(V) hydroxylamido complexes: Solid state and solution properties,” Anastasios D. Keramidas, Susie M. Miller, Oren P. Anderson and Debbie C. Crans, J. Am. Chem. Soc., 1997, 119, 8901-8915.

58. “Speciation in vanadium bioinorganic systems. 4. Interactions between vanadate, adenosine, and imidazole – an aqueous potentiometric and 51V NMR study,” Katarina Elvingston, Debbie C. Crans and Lage Pettersson, J. Am. Chem. Soc., 1997, 119, 7005-7012.

57. “Synthesis, structure and biological activity of a new insulinomimetic peroxovanadium compound: Bisperoxovanadium imidazole monoanion,” Debbie C. Crans, Anastasios D. Keramidas, Helana Hoover-Litty, Oren P. Anderson, Mary M. Miller, Lynn M. Lemoine, Susan Pleasic-Williams, Mark Vandenberg, Anthony J. Rossomando and Laurel Sweet, J. Am. Chem. Soc., 1997, 119, 5447-5448. (erratum, 1997, 4461)

56. “Six-coordinated vanadium(IV) and (V) complexes of benzimidazole and pyridyl containing ligands,” Debbie C. Crans, Anastasios D. Keramidas, Shahid S. Amin, Oren P. Anderson and Susie M. Miller, J. Chem. Soc., Dalton Transactions, 1997, 2799-2812. (See also erratum 1997, 4461)

55. “Solution and solid state properties of [N-(2-Hydroxylethyl)Iminodiacetate] Vanadium(IV), -(V) and -(IV/V) complexes,” Mohammed Mahroof-Tahir, Anastasios D. Keramidas, Ron B. Goldfarb, Oren P. Anderson, Mary M. Miller and Debbie C. Crans, Inorg. Chem., 1997, 36, 1657-1668.

54. “Syntheses, X-Ray structures and solution properties of [V4O4{(OCH2)3CCH3}3(OC2H5)3] and [V4O4{(OCH2)3CCH3}2(OCH3)6]: Examples of new ligand coordination modes,” Debbie C. Crans, Feilong Jiang, John Chen, Oren P. Anderson and Mary M. Miller, Inorg. Chem., 1997, 36, 1038-1047.

53. “Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture,” S. B. Etcheverry, Debbie. C. Crans, A. D. Keramidas and A. M. Cortizo, Arch. Biochem. Biophys., 1997, 338, 7-14.

52. “Vanadium oxoanions and cAMP-dependent protein kinase: An anti-substrate inhibitor,” Scott Pluskey, Mohammad Mahroof-Tahir, Debbie C. Crans and David S. Lawrence, Biochem. J., 1997, 321, 333-339.

51. “Protein bodies in dry germ of cereals,” Alexander Lux, Zora Hanácková, Jozef Kristín, Debbie C. Crans and Milos Mikus, Acta Universitatis Carolinae Biologica, 1997, 41, 111-119.

50. “Four- and five-coordinate oxovanadium(V) alkoxides: Do steric effects or electronic properties dictate the geometry?,” Jean Yves Kempf, Bernard Maigret and Debbie C. Crans, Inorg. Chem., 1996, 35, 6485-6494.

49. “Evidence for distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects,” Jinping Li, Gerard Elberg, Debbie C. Crans, and Yoram Shechter, Biochemistry, 1996, 35, 8314-8318.

48. “Factors affecting solution properties of vanadium(V) compounds: X-ray structure of b-cis-NH4[VO2(EDDA)],” Debbie C. Crans, Anastasios D. Keramidas, Mohammad Mahroof-Tahir, Oren P. Anderson, and Susie M. Miller, Inorg. Chem., 1996, 35, 34599-34606.

47. “Organic vanadium compounds – Transition state analogy with organic phosphorus compounds,” Debbie C. Crans, Anastasios D. Keramidas and Chryssoula Drouza, Phosphorus, Sulphur, and Silicon, 1996, 109-110, 245-248.

46. “Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents,” Debbie C. Crans, Mohammed Mahroof-Tahir and Anastasios D. Keramidas, Cell Mol. Biochemistry, 1995, 17-24.

45. “Application of NMR spectroscopy to studies of aqueous coordination chemistry of vanadium(V) complexes,” Debbie C. Crans, Paul K. Shin and Kathleen Armstrong, Mechanistic Bioinorganic Chemistry, Thorp, H. H.; Pecoraro, V. L. (Eds.) ACS Symposium Series, 1995, 246, 303-328.

44. “The effect of vanadate on growth and phospholipid levels in the root and hypocotyl of bean seedlings (Phaseolus vulgaris L.),” Milos Mikus, Paul K. Shin and Debbie C. Crans, Structure and Function of Roots, Proceedings of the 4th International Symposium on Structure and Function of Roots, Baluska, F.; Cianporova, M.; Gaspariakova; Barlow, O. (Eds.) Kluwer Academic Publishers, 1995, 181-187.

43. “Comparison of phytate in radicle, plumula, scutellum and endosperm of Zea mays and Zea diploperennis,” Milos Mikus, Alexander Lux, Debbie C. Crans, Paul K. Shin and Josef Kristin, Structure and Function of Roots, Proceedings of the 4th International Symposium on Structure and Function of Roots, Baluska, F.; Cianporova, M.; Gaspariakova; Barlow, O. (Eds.) Kluwer Academic Publishers, 1995, 175-180.

42. “Structure of the dimeric ethylene glycol- vanadate complex and other 1,2-diol-vanadate complexes in aqueous solution. Vanadate-based transition state analog complexes of phosphotransferases,” William J. Ray, Jr., Debbie. C. Crans, J. Zheng, James W. Burgner, II, H. Deng, and Mohammed Mahroof-Tahir, J. Am. Chem. Soc., 1995, 117, 6015-6026.

41. “A slow exchanging vanadium(V) peptide complex: Vanadium(V)-Gly-Tyr,” Debbie C. Crans, Hartmut Holst, Anastasios Keramidas and Dieter Rehder, Inorg. Chem., 1995, 34, 2524-2534.

40. “Phytate metabolism in bean seedlings during post-germinative growth,” Debbie C. Crans, Milos Mikus and Blayne R. Friehauf, J. Plant Physiol., 1995, 145, 101-107.

39. “The X-ray structure of (NH4)6(Gly-Gly)2V10O28•4H2O: Model studies of polyoxometalate-protein interactions,” Debbie. C. Crans, M. Mahroof-Tahir, O. P. Anderson and S. M. Miller, Inorg. Chem., 1994, 44, 5586-5590.

38. “Oxovanadium(V) alkoxide derivatives of 1,2-diols: Synthesis and solid-state 51V NMR characterization,” Debbie C. Crans, Robert A. Felty, Haojiang Chen, Hellmut Eckert and Nandini Das, Inorg. Chem., 1994, 33, 2427-2438.

37. “Characterization of vanadium(V) complexes in aqueous solutions: Ethanolamine and glycine derived complexes,” Debbie C. Crans and Paul K. Shin, J. Am. Chem. Soc., 1994, 116, 1305-1315.

36. “Interaction of polyoxovanadates and selected polyoxomolybdates with proteins,” Debbie C. Crans, Molecular Engineering, 1993, 3, 277-284.

35. “Vanadium(V)-protein model studies: Solid state and solution structure,” Debbie C. Crans, Haojiang Chen, Oren P. Anderson, and M. M. Miller, J. Am. Chem. Soc., 1993, 115, 6769-6776.

34. “NADV – a new cofactor for alcohol dehydrogenase from Thermo-anaerobium brockii,” Debbie C. Crans, Robert W. Marshman, Rikke Nielsen and Irene Felty, J. Org. Chem., 1993, 58, 2244-2252.

33. “Structural characterization and solution properties of a dimeric tetrahedral vanadium(V) chloride alkoxide,” Debbie C. Crans, Robert A. Felty, Oren P. Anderson and Mary M. Miller, Inorg. Chem., 1993, 32, 247-248.

32. “Comparison of phosphorus metabolites in various extraction procedures of Phaseolus vulgaris seeds using 31P NMR spectroscopy,” Debbie C. Crans, Milos Mikus and Robert W. Marshman, Anal. Biochem., 1993, 209, 85-94.

31. “Interaction of porcine uterine fluid purple acid phosphatase with vanadate and vanadyl cation,” Debbie C. Crans, Carmen M. Simone, Richard C. Holz and Lawrence Que, Jr., Biochemistry, 1992, 31, 11731-11739.

30. “Oxovanadium(V) 1,3-propanediolate chloride complexes – tetrameric clusters,” Debbie C. Crans, Robert W. Marshman, Miri Shaia Gottlieb, Oren P. Anderson and Mary M. Miller, Inorg. Chem., 1992, 31, 4939-4949.

29. “(-)Cryptaustoline. Its synthesis, revision of absolute stereochemistry, and mechanism of inversion of stereochemistry,” Albert I. Meyers, Thais M. Sielecki, Debbie C. Crans, Robert W. Marshman and Thank Nguyen, J. Am. Chem. Soc., 1992, 114, 8483-8489.

28. “Interaction of rabbit muscle aldolase at high ionic strengths with vanadate and other oxoanions,” Debbie C. Crans, Katakam Sudhakar and Thomas J. Zamborelli, Biochemistry, 1992, 31, 6812-6821.

27. “Chemically induced modification of cofactor specificity of glucose-6-phosphate dehydrogenase,” Debbie C. Crans, Carmen M. Simone and John S. Blanchard, J. Am. Chem. Soc., 1992, 114, 4927-4928.

26. “Synthesis and reactivity of oxovanadium(V) trialkoxides of bulky and chiral alcohols,” Debbie C. Crans, Haojiang Chen and Robert A. Felty, J. Am. Chem. Soc., 1992, 114, 4543-4550.

25. “NMR, CD and MCD studies of vanadate-nucleosides and vanadate-deoxynucleosides,” Debbie. C. Crans, Sven E. Harnung, Eric Larsen, Paul K. Shin, Lisa A. Theisen and I. Trabjerg, Acta Chem. Scand., 1991, 45, 456-462.

24. “Vanadate interactions with bovine copper, zinc-superoxide dismutase as probed by 51V NMR spectroscopy,” Lisa Wittenkeller, Aida Abraha, Ravichandran Ramasamy, Duarte Mota de Freitas, Lisa A. Theisen and Debbie C. Crans, J. Am. Chem. Soc., 1991, 113, 7872-7881.

23. “Inhibition of human seminal fluid and Leishmania donovani phosphatases by molybdate heteropolyanions,” Asish K. Saha, Debbie C. Crans, Michael T. Pope, Carmen M. Simone and Robert H. Glew, J. Biol. Chem., 1991, 266, 3511-3517.

22. “Nonreductive interaction of vanadate with an enzyme containing a thiol group in the active site: Glycerol-3-phosphate dehydrogenase,” Debbie C. Crans and Carmen M. Simone, Biochemistry, 1991, 30, 6734-6741.

21. “Substituent effects of organic vanadate esters in imidazole buffered aqueous solutions,” Debbie C. Crans, Susan M. Schelble and Lisa A. Theisen, J. Org. Chem., 1991, 56, 1266-1274.

20. “Structural and kinetic characterization of simple complexes as models for vanadate–protein interactions in aqueous solution,” Debbie C. Crans, Per Magnus Ehde, Paul K. Shin and Lage Pettersson, J. Am. Chem. Soc., 1991, 113, 3728-3736.

19. “A cyclic vanadium(V) alkoxide – An analog of the ribonuclease inhibitors,” Debbie C. Crans, Robert A. Felty and Mary M. Miller, J. Am. Chem. Soc., 1991, 113, 265-269.

18. “Vanadate dimer and tetramer both inhibit glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroidex,” Debbie C. Crans and Susan M. Schelble, Biochemistry, 1990, 29, 6698-6706.

17. “Time-resolved 51V 2-D NMR for studies of kinetic exchange between vanadate oligomers,” Debbie C. Crans, Christopher D. Rithner and Lisa A. Theisen, J. Am. Chem. Soc., 1990, 112, 2901-2908.

16. “A kinetic method for determination of free vanadium(IV) and (V) at trace level concentrations,” Debbie C. Crans, Miri Shaia Gottlieb, Jeanne Tawara, Robin L. Bunch and Lisa A. Theisen, , 1990, 180, 53-64.

15. “Vanadate tetramer as inhibiting species in enzyme reactions in vitro and in vivo,” Debbie C. Crans, Ellen M. Willging and Steven K. Butler, J. Am. Chem. Soc., 1990, 112, 427-432.

14. “Vanadate monomers and dimers both inhibit the human prostatic acid phosphatase,” Debbie C. Crans, Carmen M. Simone, Asish K. Saha and Robert H. Glew, Biochem. Biophys. Res. Comm., 1989, 165, 246-250.

13. “Interaction of trace levels of vanadium (IV) and (V) in biological systems,” Debbie C. Crans, Robin L. Bunch and Lisa A. Theisen, J. Am. Chem. Soc., 1989, 111, 7597-7607.

12. “Reversible and in situ formation of organic arsenates and vanadates as organic phosphate mimics in enzymatic reactions: Mechanistic investigation of aldol reactions and synthetic applications,” D. G. Drueckhammer, J. R. Durrwachter, R. L. Pederson, Debbie. C. Crans, L. Daniels and C-H. Wong, J. Org. Chem., 1989, 54, 70-77.

11. “Spontaneous and reversible interactions of vanadium(V) oxyanions with amine derivatives,” Debbie C. Crans and Paul K. Shin, Inorg. Chem., 1988, 27, 1797-1806.

Publications before Colorado State University:

10. “Synthesis of 3-deoxy-D-manno-2-octulosonate-8-phosphate (KDO-8-P) from D-arabinose: Generation of D-arabinose-5-phosphate using hexokinase,” Mark D. Bednarski, Debbie C. Crans, Robert DiCosimo, Ethan S. Simon, Philip D. Stein, George M. Whitesides and Marilyn J. Schneider, Tetrahedron Letters, 1988, 29, 427-430.

9. “The enantiomeric purity of polar substrates can be determined using chiral lanthanide NMR shift reagents in polar solvents,” Linda M. Sweeting, Debbie C. Crans and George M. Whitesides, J. Org. Chem., 1987, 52, 2273-2276.

8. “Enzymatic regeneration of ATP: Acetyl phosphate, phosphoenolpyruvate, methoxycarbonyl phosphate, dihydroxyacetone phosphate, 5-phospho-D-ribosyl-a-1-pyrophosphate, uridine-5′-diphosphoglucose,” Debbie C. Crans, Romas J. Kazlauskas, Bernard L. Hirshbein, Chi-Huey Wong, Obsidiana Abril and George M. Whitesides, Methods Enzymol., 1987, 136, 263-280.

7. “Glycerol kinase: Synthesis of dihydroxyacetone phosphate, syn-glycerol-3-phosphate, and chiral analogs,” Debbie C. Crans and George M. Whitesides, J. Am. Chem. Soc., 1985, 107, 7019-7027.

6. “Glycerol kinase: Substrate specificity,” Debbie C. Crans and George M. Whitesides, J. Am. Chem. Soc., 1985, 107, 7008-7018.

5. “Practical enzymatic synthesis of adenosine-5′-0-(3-thiotriphosphate) (ATP-g-S,)” Obsidiana Abril, Debbie C. Crans and George M. Whitesides, J. Org. Chem., 1984, 49, 1360-1364.

4. “A convenient synthesis of disodium acetyl phosphate for use in in situ ATP cofactor regeneration,” Debbie C. Crans and George M. Whitesides, J. Org. Chem., 1983, 48, 3130-3132.

3. “Tetracoordinate planar carbon: A singlet biradical,” Debbie C. Crans and James P. Snyder, J. Am. Chem. Soc J. Am. Chem. Soc., 1980, 102, 7152-7154.

2. “A theoretical evaluation of the synergetic capto-dative stabilization of free radicals,” Debbie C. Crans, Timothy Clark and Paul von R. Schleyer, Tetrahedron Letters, 1980, 21, 3681-3684.

1. “cis and trans-Azoalkanes: Force field determination of molecular structures, heats of formation and strain energies,” Debbie C. Crans and James P. Snyder, Chem. Ber., 1980, 113, 1201-1204.